Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration

Journal of Neuroscience

Volumn 20, Issue 2, 2000, Pages 660-665

  Gong, Yun H ^a   Parsadanian, Alexander S ^b   Andreeva, Albina ^a   Snider, William D ^c   Elliott, Jeffrey L ^a,d  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Amyotrophic lateral sclerosis; Glia; Gliosis; Glutamate; Mouse; Transgenic

Indexed keywords

SUPEROXIDE DISMUTASE;

ALTERNATIVE RNA SPLICING; AMINO ACID TRANSPORT; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL TISSUE; ARTICLE; ASTROCYTE; AUTOPSY; GLIOSIS; MICROGLIA; MOTONEURON; MOUSE; NERVE DEGENERATION; NERVE INJURY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034651102     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-02-00660.2000     Document Type: Article

References (30)

1. Acarin L, Vela JM, Gonzalez B, Castellano B (1994) Demonstration of poly-N-acetyl lactosamine residues in amoeboid and ramified microglial cells in rat brain by tomato lectin binding. J Histochem Cytochem 42:1033-1041.
2. Bai G, Lipton SA (1998) Aberrant RNA splicing in sporadic amyotrophic lateral sclerosis. Neuron 20:353-366.
3. Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, Brown Jr RH (1997) Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol 42:646-654.
4. Bogdanov MB, Ramos L, Xu Z, Beal MF (1998) Elevated hydroxyl radical generation in vivo in an animal model of amyotrophic lateral sclerosis. J Neurochem 71:1321-1324.
5. Brenner M, Kissebeth WC, Su Y, Besnard F, Messing A (1994) GFAP promoter directs astrocyte- specific expression in transgenic mice. J Neurosci 14:1030-1037.
6. Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, Sisodia SS, Rothstein JD, Borchelt DR, Price DL, Cleveland DW (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18:327-338.
7. Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldsone MB, Mucke L (1993) Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 90:10061-10065.
8. Canton T, Pratt J, Stutzmann JM, Boireau A (1998) Glutamate uptake is decreased tardively in the spinal cord of FALS mice. NeuroReport 9:775-778.
9. Chavany C, Vicario-Abejon C, Miller G, Jendobi, M (1998) Transgenic mice for interleukin 3 develop motor neuron degeneration associated with auto immune reaction against spinal cord motor neurons. Proc Natl Acad Sci USA 95:11354-11359.
10. Crow JP, Sampson JB, Zhuang Y, Thompson JA, and Beckman JS (1997) Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J Neurochem 69:1936-1944.
11. Dal Canto MC, Gurney ME (1994) Development of central nervous system pathology in a murine transgenic model of ALS. Am J Pathol 145:1271-1280.
12. Deckwerth TL, Elliott JL, Knudson CM, Johnson Jr EM, Snider WD, Korsmeyer SJ (1996) Bax is required for neuronal death after trophic factor deprivation and during development. Neuron 17:401-411.
13. Ferrante RJ, Shinobu LA, Schulz JB, Mattews RT, Thomas CE, Kowall NW, Gurney ME, Beal MF (1997) Increased 3-nitrotyrosine and oxidative damage in mice with human copper/zinc superoxide dismutase mutation. Ann Neurol 42:326-334.
14. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, Chen W, Zhai P, Sufit RL, Siddique T (1994) Motor neuron degeneration in mice that express a human Cu,Zn dismutase mutation. Science 264:1772-1775.
15. Kliveny P, Ferrante RJ, Mattews RT, Bogdanov MB, Klein AM, Andrassen OA, Mueller G, Wermer M, Kaddurah-Daouk R, Beal MF (1999) Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 5:347-350.
16. Lin CLG, Bristol LA, Jin L, Dykes-Hoberg M, Crawford T, Clawson L, and Rothstein JD (1998) Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter in amyotrophic lateral sclerosis. Neuron 20:589-602.
17. Parsadanian ASh, Cheng Y, Keller-Peck C, Holztman DM, Snider WD (1998) Bcl-xL is an antiapoptotic regulator for postnatal CNS neurons. J Neurosci 18:1009-1019.
18. Pedersen WA, Fu W, Keller JN, Markesberry WR, Appel SA, Smith RG, Kasarkis E, Mattson MP (1998) Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann Neurol 44:819-824.
19. Raeber AJ, Race RE, Brandner S, Priola SA, Sailer A, Bessen RA, Mucke L, Manson J, Aguzzi A, Oldstone MB, Weissmann C, Chesebro B (1997) Astrocy te specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie. EMBO J 16:6057-6065.
20. Reaume AG, Elliott JL, Hoffman EK, Kowal NW, Ferrante RJ, Siwek DF, Wilcox HM, Flood DG, Beal MF, Brown RH, Scott RW, Snider WD (1996) Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 13:43-47.
21. Ripps M E, Huntley GW, Hof PR, Morrison JH, and Gordon JW (1995) Transgenic mice expressing an altered superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 92:689-693.
22. Rosen DR, Sidduqe T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, Rahmani Z, Krizus A, McKenna-Yasek, D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Van den Bergh R, Hung WY, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Perciak-Vance MA, Haines J, Roulou GA, Gusella JS, Horvitz HR, Brown Jr RH (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62.
23. Rothstein JD, Martin LJ, Kuncl RW (1992) Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. New Engl J Med 326:1464-1468.
24. Rothstein JD, Martin L, Levey AI, Dykes-Hoberg M, Jin L, Wu D, Nash N, Kuncl RW (1994) Localization of neuronal and glial glutamate transporters. Neuron 13:713-725.
25. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38:73-84.
26. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF (1996) Knockout of glutamate transporters reveals a major role of for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16:675-686.
27. Swanson RA, Liu J, Miller JW, Rothstein JD, Farrell K, Stein BA, Longuemare MC (1997) Neuronal regulation of glutamate subtype expression in astrocytes. J Neurosci 17:932-940.
28. Trotti D, Rolfs A, Danbolt NC, Brown Jr RH, Hediger MA (1999) SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat Neurosci 2:427-433.
29. Tu PH, Rau P, Robinson KA, Gurney ME, Trojanowski JQ, and Lee V (1996) Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sci USA 93:3155-3160.
30. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, Sisodia SS, Cleveland DW, Price DL (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14:1105-1116.